Author:
Díaz Méndez Ana Belén,Sacconi Andrea,Tremante Elisa,Lulli Valentina,Caprara Valentina,Rosanò Laura,Goeman Frauke,Carosi Mariantonia,Di Giuliani Marta,Vari Giulia,Silvani Antonio,Pollo Bianca,Garufi Carlo,Ramponi Sara,Simonetti Giorgia,Ciusani Emilio,Mandoj Chiara,Scalera Stefano,Villani Veronica,Po Agnese,Ferretti Elisabetta,Regazzo Giulia,Rizzo Maria Giulia
Abstract
Abstract
Background
Altered microRNA profiles have been observed not only in tumour tissues but also in biofluids, where they circulate in a stable form thus representing interesting biomarker candidates. This study aimed to identify a microRNA signature as a non-invasive biomarker and to investigate its impact on glioma biology.
Methods
MicroRNAs were selected using a global expression profile in preoperative serum samples from 37 glioma patients. Comparison between serum samples from age and gender-matched controls was performed by using the droplet digital PCR. The ROC curve and Kaplan-Meier survival analyses were used to evaluate the diagnostic/prognostic values. The functional role of the identified signature was assessed by gain/loss of function strategies in glioma cells.
Results
A three-microRNA signature (miR-1-3p/−26a-1-3p/−487b-3p) was differentially expressed in the serum of patients according to the isocitrate dehydrogenase (IDH) genes mutation status and correlated with both patient Overall and Progression Free Survival. The identified signature was also downregulated in the serum of patients compared to controls. Consistent with these results, the signature expression and release in the conditioned medium of glioma cells was lower in IDH-wild type cells compared to the mutated counterpart. Furthermore, in silico analysis of glioma datasets showed a consistent deregulation of the signature according to the IDH mutation status in glioma tumour tissues. Ectopic expression of the signature negatively affects several glioma functions. Notably, it impacts the glioma invasive phenotype by directly targeting the invadopodia-related proteins TKS4, TKS5 and EFHD2.
Conclusions
We identified a three microRNA signature as a promising complementary or even an independent non-invasive diagnostic/prognostic biomarker. The signature displays oncosuppressive functions in glioma cells and impacts on proteins crucial for migration and invasion, providing potential targets for therapeutic intervention.
Funder
H2020 Marie Skłodowska-Curie Actions
Mia Neri Foundation
Associazione Italiana per la Ricerca sul Cancro
Ministero della Salute
Publisher
Springer Science and Business Media LLC
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献